Skip to main content
Erschienen in: International Urogynecology Journal 4/2022

01.12.2021 | Commentary

Commentary on ‘A randomized trial comparing continence pessary to continence device (Poise Impressa®)’

verfasst von: Abdelmageed Abdelrahman

Erschienen in: International Urogynecology Journal | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Excerpt

This is a multi-centred randomized controlled trial evaluating stress urinary incontinence (SUI) treatment based on the Patient Global Impression of Improvement score after 4 weeks using a continence pessary (CP) or a disposable intravaginal continence device (DICD). The trial studied women with SUI or stress predominant mixed urinary incontinence (MUI) at two academic medical centres located in the USA. Participants were randomized to either DICD or CP in a 1:1 allocation ratio for a 4-week treatment period followed by a 6-month phone call follow-up. Exclusion criteria included pregnancy, contraindication to or prior treatment with CP/DICD, and prior SUI surgery. …
Metadaten
Titel
Commentary on ‘A randomized trial comparing continence pessary to continence device (Poise Impressa®)’
verfasst von
Abdelmageed Abdelrahman
Publikationsdatum
01.12.2021
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 4/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-021-05019-y

Weitere Artikel der Ausgabe 4/2022

International Urogynecology Journal 4/2022 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.